Reasons behind AP treatment failure include drug malabsorption during administration of the drug without fatty food in subtherapeutic serum levels (8, 9) C/N/S mutants in the 268 cytb codon, insufficient dosage (10), and obesity (11). This evidence concerns the gene MT-CYB and alkaline phosphatase measurement.